Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT00319306
Other study ID # D5890L00012
Secondary ID RELEASE
Status Completed
Phase Phase 3
First received April 27, 2006
Last updated March 16, 2009
Start date September 2005
Est. completion date December 2006

Study information

Verified date March 2009
Source AstraZeneca
Contact n/a
Is FDA regulated No
Health authority United Kingdom: Medicines and Healthcare Products Regulatory Agency
Study type Interventional

Clinical Trial Summary

The purpose of this study is to determine whether patients with asthma are better able to manage and control their symptoms by using one inhaler daily that both prevents as well as treats the symptoms of an asthma exacerbation.


Recruitment information / eligibility

Status Completed
Enrollment 550
Est. completion date December 2006
Est. primary completion date
Accepts healthy volunteers No
Gender Both
Age group 18 Years and older
Eligibility Inclusion Criteria:

- Aged over 18

- Confirmed diagnosis of mild to moderate asthma by doctor

- Currently receiving inhaled corticoid-steroid medicine for treatment of asthma and requiring a review of current asthma treatment

Exclusion Criteria:

- Women who are pregnant, breast-feeding, or planning pregnancy

- Patients with a history of chronic obstructive pulmonary disease

- Patients using any beta blocker therapy

- Patients receiving steroid tablets or steroid injections

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment


Related Conditions & MeSH terms


Intervention

Drug:
Budesonide/formoterol

Device:
Symbicort® Turbohaler®


Locations

Country Name City State
United Kingdom Research Site Airdrie Lanarkshire
United Kingdom Research Site Ashford
United Kingdom Research Site Atherstone
United Kingdom Research Site Ayrshire
United Kingdom Research Site Barry South Glamorgan
United Kingdom Research Site Bath
United Kingdom Research Site Blackpool
United Kingdom Research Site Bolton
United Kingdom Research Site Box Wiltshire
United Kingdom Research Site Bradford-On-Avon Wiltshire
United Kingdom Research Site Cardiff
United Kingdom Research Site Carrickfergus
United Kingdom Research Site Chase Terrace Staffordshire
United Kingdom Research Site Cheshire
United Kingdom Research Site Chesterfield
United Kingdom Research Site Cookstown Northern Ireland
United Kingdom Research Site Coventry
United Kingdom Research Site Crawley West Sussex
United Kingdom Research Site Dartford Kent
United Kingdom Research Site Doncaster North Yorkshire
United Kingdom Research Site Downpatrick Northern Ireland
United Kingdom Research Site Dundee
United Kingdom Research Site East Horsley Surrey
United Kingdom Research Site Ellesmere Port
United Kingdom Research Site Fife
United Kingdom Research Site Fowey Cornwall
United Kingdom Research Site Glasgow
United Kingdom Research Site Glenrothes Fife
United Kingdom Research Site Hamilton Lanarkshire
United Kingdom Research Site Harrow
United Kingdom Research Site Hove East Sussex
United Kingdom Research Site Ilford Essex
United Kingdom Research Site Larne
United Kingdom Research Site Leeds
United Kingdom Research Site Middlesborough
United Kingdom Research Site Newcastle
United Kingdom Research Site Newtownabbey
United Kingdom Research Site Peterhead
United Kingdom Research Site Pontypridd
United Kingdom Research Site Reading
United Kingdom Research Site Rugby
United Kingdom Research Site Rutherglen
United Kingdom Research Site Sandy
United Kingdom Research Site Sheffield
United Kingdom Research Site Stafford
United Kingdom Research Site Stevenage
United Kingdom Research Site Stockport
United Kingdom Research Site Sunbury on Thames
United Kingdom Research Site Sutton Coldfield
United Kingdom Research Site Tilehurst
United Kingdom Research Site Tonbridge
United Kingdom Research Site Trowbridge
United Kingdom Research Site Vale of Glamorgan
United Kingdom Research Site Warminster
United Kingdom Research Site Watford
United Kingdom Research Site Wells next the Sea
United Kingdom Research Site Westbury
United Kingdom Research Site Woking
United Kingdom Research Site Yaxley

Sponsors (1)

Lead Sponsor Collaborator
AstraZeneca

Country where clinical trial is conducted

United Kingdom, 

Outcome

Type Measure Description Time frame Safety issue
Primary In a real life setting, to compare Symbicort® Single Inhaler Therapy with a patient's previous therapy (including low dose ICS), by assessment of the changes in the Asthma Control Questionnaire score in uncontrolled asthmatic patients.
Secondary Change in forced expiratory volume in one second (FEV1)
Secondary Change in peak expiratory flow (PEF)
Secondary Patient Reported Outcomes: AQLQ(S), SATQ, RCP-3 scores
See also
  Status Clinical Trial Phase
Terminated NCT04410523 - Study of Efficacy and Safety of CSJ117 in Patients With Severe Uncontrolled Asthma Phase 2
Completed NCT04624425 - Additional Effects of Segmental Breathing In Asthma N/A
Active, not recruiting NCT03927820 - A Pharmacist-Led Intervention to Increase Inhaler Access and Reduce Hospital Readmissions (PILLAR) N/A
Completed NCT04617015 - Defining and Treating Depression-related Asthma Early Phase 1
Recruiting NCT03694158 - Investigating Dupilumab's Effect in Asthma by Genotype Phase 4
Terminated NCT04946318 - Study of Safety of CSJ117 in Participants With Moderate to Severe Uncontrolled Asthma Phase 2
Completed NCT04450108 - Vivatmo Pro™ for Fractional Exhaled Nitric Oxide (FeNO) Monitoring in U.S. Asthmatic Patients N/A
Completed NCT03086460 - A Dose Ranging Study With CHF 1531 in Subjects With Asthma (FLASH) Phase 2
Completed NCT01160224 - Oral GW766944 (Oral CCR3 Antagonist) Phase 2
Completed NCT03186209 - Efficacy and Safety Study of Benralizumab in Patients With Uncontrolled Asthma on Medium to High Dose Inhaled Corticosteroid Plus LABA (MIRACLE) Phase 3
Completed NCT02502734 - Effect of Inhaled Fluticasone Furoate on Short-term Growth in Paediatric Subjects With Asthma Phase 3
Completed NCT01715844 - L-Citrulline Supplementation Pilot Study for Overweight Late Onset Asthmatics Phase 1
Terminated NCT04993443 - First-In-Human Study to Evaluate the Safety, Tolerability, Immunogenicity, and Pharmacokinetics of LQ036 Phase 1
Completed NCT02787863 - Clinical and Immunological Efficiency of Bacterial Vaccines at Adult Patients With Bronchopulmonary Pathology Phase 4
Recruiting NCT06033833 - Long-term Safety and Efficacy Evaluation of Subcutaneous Amlitelimab in Adult Participants With Moderate-to-severe Asthma Who Completed Treatment Period of Previous Amlitelimab Asthma Clinical Study Phase 2
Completed NCT03257995 - Pharmacodynamics, Safety, Tolerability, and Pharmacokinetics of Two Orally Inhaled Indacaterol Salts in Adult Subjects With Asthma. Phase 2
Completed NCT02212483 - Clinical Effectiveness and Economical Impact of Medical Indoor Environment Counselors Visiting Homes of Asthma Patients N/A
Recruiting NCT04872309 - MUlti-nuclear MR Imaging Investigation of Respiratory Disease-associated CHanges in Lung Physiology
Withdrawn NCT01468805 - Childhood Asthma Reduction Study N/A
Recruiting NCT05145894 - Differentiation of Asthma/COPD Exacerbation and Stable State Using Automated Lung Sound Analysis With LungPass Device